HOME >> MEDICINE >> NEWS
The Lancet Oncology and The Lancet Infectious Diseases

THE LANCET ONCOLOGY

THE TRUE COST OF A NUCLEAR DETERRENT

This months editorial covers the recent leaked report from the US Department of Health and Disease Control, showing the patterns of nuclear fallout across the US resulting from Cold War testing. The editorial discusses the impact of these data on cancer incidence and the worldwide effects of nuclear testing on the general population and military personnel. It concludes: 'It is easy to say that lessons should be learnt from the history of the nuclear deterrent, but unfortunately, with the escalation of the nuclear race in India and Pakistan, and the possibility of terrorist groups such as al-Qaeda acquiring materials to create crude nuclear devices, it is likely that the same mistakes will be repeated. We may never fully realise the true human cost of military advancement.'

REVIEWS

  • The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators
  • Use of minimally invasive oesophagectomy for cancer of the oesophagus
  • Clinical management of dyspnoea
  • Mediastinal (thymic) large B-cell lymphoma: where do we stand?
  • Culprit and victim - DNA topoisomerase II
  • Cancer causation: the Darwinian downside of past success?

THE LANCET INFECTIOUS DISEASES

ENOUGH TIME WASTED IN SOUTH AFRICA

This months Leading Edge editorial discusses the South African Governments reluctance to provide the antiretroviral drug nevirapine to pregnant women with HIV. The drug has been shown to be effective in preventing mother-to-child HIV-1 transmission; however the South African Government have recently launched an appeal to a March 11 court hearing which instructed them to make the drug available in state facilities offering HIV-1 counselling and testing.

REVIEWS

  • Epidemiology of drug-resistant malaria
  • p values for pathogens: statistica
    '"/>


Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
1-Apr-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. The Lancet Neurology November press release
7. Lancet readers to join WHO election debate
8. The Lancet Oncology press release
9. The Lancet Neurology October press release
10. The Lancet neurology press release
11. The Lancet Neurology press release

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Lancet Oncology and The Lancet Infectious Diseases

(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader ... spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof at ... at the Olympia London, booth #F33 , Be the first to get a sneak ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes Carol Wysham to ... additional of Carol Wysham, MD, to their esteemed Board of Directors. Dr. Wysham ... David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and Vicki Norris. ...
(Date:9/3/2015)... ... , ... ProScrub is a set of automated tools that allow Final Cut ... effects without the use of keyframes. Utilize ProScrub's powerful sliders to determine the ... complements to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... AvePoint, ... that AvePoint Perimeter Service Pack (SP) 4 – AvePoint’s solution for facilitating ... named a “KMWorld 2015 Trend-Setting Product”. This is the fifth consecutive year ...
(Date:9/3/2015)... ... September 03, 2015 , ... Representatives with State Farm ... highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , “We will be ... Biloxi, and beyond. We will be discussing setting up college funds, offering information ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... the "New EU Pharmacovigilance Legislation (London, UK - ... The 15 new EU modules concerning Pharmacovigilance ... Pharmacovigilance is conducted in Europe . ... these modules and their requirements, examine how they overlap ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
Cached News: